Walsh Medical Media

Reviewer Description:

University:

Country:

Reviewer Photo:

Note: Photo must be less than 4 kilobytes and width* height is 85*119

Reviewer Biography:

2021/07 – 2023 University of Freiburg, Germany Ph.D. in Biology 08/2018 – 08/2020 University of Notre Dame, Indiana, US M.S. in Biology of Science 09/2013 – 06/2017 University of Electronic Science and Technology of China, China B.A Biotechnology

TEACHING EXPERIENCE 08/2018 – 08/2020, Teaching Assistant, University of Notre Dame Introduction in Cell Biology 08/2018 - 12/2018; 01/2020 – 05/2020 Microbiology 01/2019 – 05/2019 Cell Biology 08/2019 – 12/2019

RESEARCH EXPERIENCE 09/2021 – 09/2022 Research Assistant, University Medical Center Freiburg, Germany ? Establish anti-PD1 and radiation-resistant tumor models ? Record the survival and tumor curves of mice receiving either combination or monoclonal therapy. ? Identify the underlying mechanism of the combination therapies that enhance therapeutic outcomes. 08/2018 – 10/2020 MSc. student, University of Notre Dame, USA Department of Biological Science Advisor: Dr. Xin Lu Eradicate Metastasis by Co-targeting PD1 and LAG3, OX40 or CD47 Signaling 08/2019– 08/2020 ? Establish anti-PD1 resistant metastatic models of colorectal cancer (liver metastasis) and ovarian cancer (peritoneal cavity metastasis) ? Identify the immune cell composition and expression pattern of PD1/PD-L1, LAG3/MHC-II, OX40/OX40L, CD47/SIRPα in cancer cells and immune cells of the anti-PD1 resistant metastasis models ? Determine the therapeutic effect of combining anti-PD1 with anti-LAG3, anti-OX40 or anti-CD47 in the anti-PD1 resistant metastatic models

Reviewer Research Intrest:

Reviewer Acceptance Letter: reviewer-meidan-wang-4328.pdf

Journal Name : Add/Edit Reviewer Member

Journal Name :
Add/Edit Reviewer Member